105 oral Analysis of acute and late morbidity, and biochemical control for intermediate to high risk prostate cancer treated with androgen deprivation, HDR and 3D/IMRT: 4 year results of a phase I-II dose escalation trial
Keyword(s):
Phase I
◽
Keyword(s):
2019 ◽
Vol 105
(1)
◽
pp. E596
2020 ◽
Vol 108
(3)
◽
pp. e869
2020 ◽
Vol 106
(5)
◽
pp. 939-947
2021 ◽
Vol 26
(2)
◽
pp. 188-195
2012 ◽
Vol 20
(8)
◽
pp. 798-805
◽
2015 ◽
Vol 93
(3)
◽
pp. E238-E239